Publications by authors named "Alexander Winkelmann"

Claim this Profile
A
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.
Carolin Schwake, Theodoros Ladopoulos, Vivien Häußler, Ingo Kleiter, Marius Ringelstein, Alexander Winkelmann

J Neurol Neurosurg Psychiatry· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.
Michael Hecker, Brit Fitzner, Isis Ludwig-Portugall, Friederike Bohne, Edmar Heyland, Alexander Winkelmann

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study.
Alexander Winkelmann, Emil C Reisinger, Katharina Boden, Christoph Metze, Uwe K Zettl

Vaccines (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision.
Mihaela Nicolescu, Vivien Häußler, Friedemann Paul, Frederike Cosima Oertel, Patrick Schindler, Alexander Winkelmann

J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapse.
Michael Hecker, Brit Fitzner, Dirk Koczan, Juliane Klehmet, Matthias Grothe, Alexander Winkelmann

Biomed Pharmacother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
Ankelien Duchow, Judith Bellmann-Strobl, Tim Friede, Orhan Aktas, Klemens Angstwurm, Alexander Winkelmann

Ann Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study.
Alexander Winkelmann, Christoph Metze, Uwe K Zettl, Micha Loebermann

Sci Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy.
Michael Hecker, Brit Fitzner, Nina Boxberger, Elena Putscher, Robby Engelmann, Alexander Winkelmann

J Neuroinflammation· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.
Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, Maria Pia Amato, Tobias Derfuss, Alexander Winkelmann

Mult Scler· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis.
Michael Hecker, Brit Fitzner, Elena Putscher, Margit Schwartz, Alexander Winkelmann

EBioMedicine· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of Nabiximols Dose to Steady-State Concentrations of Cannabinoids in Urine Samples from Patients with Multiple Sclerosis.
Rüdiger Birke, Stefanie Meister, Alexander Winkelmann, Burkhard Hinz, Udo I Walther

J Clin Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination and immunotherapies in neuroimmunological diseases.
Alexander Winkelmann, Micha Loebermann, Michael Barnett, Hans-Peter Hartung, Uwe K Zettl

Nat Rev Neurol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].
Tobias Monschein, Tobias Zrzavy, Micha Löbermann, Alexander Winkelmann, Thomas Berger

Nervenarzt· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].
Tobias Monschein, Tobias Zrzavy, Micha Löbermann, Alexander Winkelmann, Thomas Berger

Nervenarzt· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis.
Tobias Zrzavy, Esther Daniels, Niklas Stuka, Dennis Weber, Alexander Winkelmann

Ther Adv Chronic Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study.
Stephan Blechinger, Johannes Ehler, Gabriel Bsteh, Alexander Winkelmann, Fritz Leutmezer

Ther Adv Neurol Disord· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination in Multiple Sclerosis: Friend or Foe?
Tobias Zrzavy, Herwig Kollaritsch, Paulus S Rommer, Nina Boxberger, Micha Loebermann, Alexander Winkelmann

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tick-borne encephalitis vaccination in multiple sclerosis: A prospective, multicenter study.
Alexander Winkelmann, Christoph Metze, Silvius Frimmel, Emil C Reisinger, Uwe K Zettl

Neurol Neuroimmunol Neuroinflamm· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Indications for varicella zoster and herpes zoster vaccination in multiple sclerosis: current situation].
Alexander Winkelmann, Micha Löbermann, Uwe K Zettl

Nervenarzt· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies.
Christoph Metze, Alexander Winkelmann, Micha Loebermann, Michael Hecker, Brunhilde Schweiger

CNS Neurosci Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene.
Michael Hecker, Nina Boxberger, Nicole Illner, Brit Fitzner, Ina Schröder, Alexander Winkelmann

PLoS Genet· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period.
Alexander Winkelmann, Paulus Stefan Rommer, Michael Hecker, Uwe Klaus Zettl

CNS Neurosci Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine-1-phosphate receptor modulator.
Ines C Angerer, Michael Hecker, Dirk Koczan, Luisa Roch, Jörg Friess, Alexander Winkelmann

CNS Neurosci Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis.
Jörg Friess, Michael Hecker, Luisa Roch, Dirk Koczan, Brit Fitzner, Alexander Winkelmann

Sci Rep· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Sven Jarius, Ingo Kleiter, Klemens Ruprecht, Nasrin Asgari, Kalliopi Pitarokoili, Alexander Winkelmann

J Neuroinflammation· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis